A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

Clinical trial NCT02797795 · COMPLETED

Trial details

NCT number: NCT02797795
Sponsor: Neovia Oncology Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Solid Tumors

Start date: 2016-12-01
Primary completion: 2023-12-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.